Recombinant Cicadin

Shipped with Ice Packs
In Stock

Description

Origin and Isolation of Native Cicadin

Cicadin was first isolated from dried juvenile cicadas (Cryptotympana pustulata) and characterized as a novel antifungal peptide. Key features include:

  • Molecular weight: ~4–6 kDa (exact mass unspecified in available literature) .

  • Structural motifs: Enriched in tryptophan residues, which are critical for membrane interaction and antifungal activity .

  • Source: Naturally produced in cicadas as part of their innate immune defense .

Antifungal Activity and Mechanisms

Cicadin exhibits broad-spectrum antifungal activity, with studies highlighting its efficacy against pathogens such as Candida albicans, Aspergillus niger, and Saccharomyces cerevisiae.

Table 1: Antifungal Activity of Cicadin

PathogenMinimum Inhibitory Concentration (MIC)Mechanism of Action
Candida albicansNot explicitly reportedDisruption of plasma membrane integrity
Aspergillus nigerNot explicitly reportedInteraction with lipid bilayers
Saccharomyces cerevisiaeNot explicitly reportedPermeabilization of cell membranes
  • Mechanistic insights:

    • Tryptophan residues enable cicadin to anchor at the lipid bilayer interface, destabilizing fungal membranes .

    • Mimics cationic antimicrobial peptides (AMPs), leveraging electrostatic interactions with negatively charged microbial surfaces .

Table 2: Key Challenges in Recombinant Cicadin Synthesis

ChallengeDescriptionSolution from Analogous Systems
Low yieldShort peptides are prone to proteolytic degradation in hosts.Fusion with stabilizing tags (e.g., SUMO)
Refolding requirementsRecombinant peptides often require denaturation and refolding for activity.Use of solubilization tags (e.g., GST)
Cost and complexityRecombinant systems are labor-intensive compared to chemical synthesis.Optimized expression vectors (e.g., pET)
  • Case study: Recombinant insulin production (51 amino acids) faced similar hurdles, resolved via E. coli expression systems with codon optimization .

Research Gaps and Future Directions

  • Structural characterization: No high-resolution NMR or crystallographic data exists for cicadin, limiting rational engineering.

  • Scalability: Current yields from recombinant systems remain unquantified in published studies.

  • Clinical potential: Synergy with existing antifungals (e.g., azoles) warrants exploration .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but if you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance, as additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
Cicadin; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-55
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Cicada flammata
Target Protein Sequence
NEYHGFVDKA NNENKRKKQQ GRDDFVVKPN NFANRRRKDD YNENYYDDVD AADVV
Uniprot No.

Target Background

Function
Cicadin exhibits antifungal activity against B. cinerea, M. arachidicola, F. oxysporum, R. solani, and C. comatus. It also suppresses HIV-1 reverse transcriptase activity and stimulates murine splenocyte proliferation.

Q&A

What is Recombinant Cicadin and how is it produced?

Recombinant Cicadin refers to a protein derived from cicada species that is produced through recombinant DNA technology in heterologous expression systems. The production process typically involves:

  • Extraction of high-quality DNA from cicada samples, ideally using fresh cicada exuviae which provide sufficient DNA for subsequent molecular applications

  • Amplification of the cicadin gene using optimized PCR protocols specific for cicada-derived DNA

  • Cloning of the gene into appropriate expression vectors

  • Transformation into a suitable host system, most commonly E. coli

  • Expression under controlled conditions using multivariant experimental design approaches to maximize soluble protein yield

The approach shares similarities with recombinant protein expression systems like those used for pneumolysin (Ply), where researchers have achieved high yields (250 mg/L) of soluble protein with 75% homogeneity through careful optimization of expression conditions .

What are the fundamental structural characteristics of Recombinant Cicadin?

Recombinant Cicadin's structure must be carefully preserved during expression to maintain functionality. Similar to complex proteins like RecBCD enzyme, Recombinant Cicadin likely contains:

  • Multiple functional domains that contribute to its biological activity

  • Specific binding regions that determine interaction with target molecules

  • Conformational elements critical for proper function

  • Potential subunit structure requiring proper assembly for activity

Understanding these structural characteristics requires analysis through techniques such as X-ray crystallography, cryoEM, and molecular modeling approaches, similar to those used to study complex enzymes like RecBCD .

What expression systems are most appropriate for Recombinant Cicadin?

The selection of an appropriate expression system depends on several factors:

Expression SystemAdvantagesLimitationsBest For
E. coliHigh yields, rapid growth, economical, well-established protocolsLimited post-translational modifications, potential for inclusion body formationInitial expression screening, structural studies, high-yield production
YeastEukaryotic post-translational modifications, secretion possibleLonger processing time, potential glycosylation differencesProteins requiring specific modifications
Insect cellsNear-native cicada protein modifications, proper foldingHigher cost, more complex methodologyFunctional studies requiring authentic protein
Mammalian cellsComplete post-translational processingHighest cost, lowest yieldsTherapeutic applications, complex protein studies

E. coli remains the most commonly used system due to its cost-effectiveness and the availability of optimization strategies for improving soluble expression, as demonstrated in studies using multivariant experimental design approaches .

What are the optimal conditions for expression of soluble Recombinant Cicadin?

Based on experimental design approaches for recombinant proteins, the following factors should be systematically evaluated to maximize soluble Cicadin expression:

  • Temperature: Lower induction temperatures (15-25°C) often promote proper folding and increase solubility

  • Inducer concentration: Optimizing IPTG levels to balance expression rate with protein folding

  • Media composition: Enriched media containing glucose, glycerol, and amino acid supplements

  • Induction timing: Typically at mid-log phase (OD600 of 0.6-0.8)

  • Expression duration: 4-6 hours is often optimal, as longer periods may reduce productivity

A fractional factorial screening design (2^8-4) with central point replicates offers an efficient approach to identify statistically significant variables affecting expression, allowing researchers to gather high-quality information with fewer experiments .

How can DNA extraction from cicada samples be optimized for recombinant expression?

Efficient DNA extraction is critical for successful cloning and expression of Cicadin. Recent research demonstrates that:

  • Fresh cicada exuviae provide high-quality DNA suitable for microsatellite genotyping and likely gene cloning

  • Non-invasive sampling methods using exuviae are particularly valuable for endangered or endemic cicada species

  • PCR amplification protocols can be optimized specifically for exuviae-derived DNA

  • Standard extraction methods (phenol-chloroform or column-based) can be modified to accommodate the specific nature of cicada samples

This approach offers significant advantages when studying rare cicada species or when large sample numbers are required for comprehensive analysis .

What purification strategies yield the highest purity and activity for Recombinant Cicadin?

Optimal purification strategies balance high purity with preserved biological activity:

Purification StepMethodCritical Considerations
Initial CaptureAffinity chromatography (His-tag, GST, etc.)Tag position to minimize interference with activity
Intermediate PurificationIon exchange chromatographyBuffer pH and salt concentration optimization
PolishingSize exclusion chromatographyBuffer composition to maintain solubility
Tag RemovalSite-specific protease cleavageComplete removal confirmation via mass spectrometry

Throughout purification, activity assays should be performed to ensure the biological function is maintained. A common challenge is balancing purification stringency with activity preservation, often requiring optimization of buffer conditions (pH, ionic strength, stabilizing additives) .

How can structural comparisons between recombinant and native Cicadin inform functional studies?

Structural comparison analyses provide crucial insights into protein authenticity and functional characteristics:

  • Secondary structure analysis using circular dichroism can confirm proper folding

  • Mass spectrometry can identify post-translational modifications present in native but absent in recombinant versions

  • X-ray crystallography and cryoEM approaches reveal detailed structural information

  • Functional assays comparing native and recombinant forms help identify critical structural elements

Studies on complex proteins like RecBCD have demonstrated how structural analysis can reveal conformational changes associated with activity, providing a roadmap for similar analyses of Recombinant Cicadin .

What strategies can address expression challenges for difficult-to-express Cicadin variants?

Expression of challenging protein variants requires specialized approaches:

  • Codon optimization based on host organism preferences

  • Fusion partners to enhance solubility:

    • MBP (Maltose Binding Protein)

    • SUMO (Small Ubiquitin-like Modifier)

    • Thioredoxin

  • Co-expression with molecular chaperones (GroEL/ES, DnaK/J)

  • Directed evolution strategies to select for variants with improved expression

  • Periplasmic targeting to facilitate disulfide bond formation

  • Cell-free expression systems for highly toxic variants

These approaches can be evaluated systematically using the experimental design methodology described for recombinant protein expression .

How can site-directed mutagenesis be used to investigate structure-function relationships in Recombinant Cicadin?

Site-directed mutagenesis provides powerful insights into protein functionality:

  • Alanine scanning mutagenesis to identify essential residues

  • Conservative substitutions to probe specific chemical requirements

  • Domain swapping between related proteins to map functional regions

  • Introduction of reporter groups (cysteine residues for fluorescent labeling)

  • Mutation of potential post-translational modification sites

Similar approaches have been successfully used with complex enzymes like RecBCD, where "mutants have given deep insights into how the multiple activities of this complex enzyme are coordinated and how it acts in living cells" .

What are the primary causes of low expression yields and how can they be addressed?

When facing low expression yields, consider these systematic troubleshooting approaches:

ProblemPossible CausesSolution Strategies
Toxic protein effectsInterference with host cell processesUse tight expression control, lower temperature
Inclusion body formationRapid expression exceeding folding capacityReduce inducer concentration, lower temperature
Poor translation efficiencyRare codons, poor ribosome bindingCodon optimization, optimize ribosome binding site
Proteolytic degradationRecognition by host proteasesUse protease-deficient strains, optimize harvest timing
Poor plasmid stabilitySelective pressure against expressed proteinCheck antibiotic resistance, use fresh transformants

Statistical experimental design enables efficient identification of significant variables affecting expression, as demonstrated in studies achieving 250 mg/L of soluble recombinant protein .

How can protein solubility issues be resolved during expression and purification?

Improving protein solubility requires a multi-faceted approach:

  • Expression modifications:

    • Reduced induction temperature (15-20°C)

    • Lower inducer concentration

    • Co-expression with solubility-enhancing factors

  • Buffer optimization during purification:

    • Addition of solubilizing agents (low concentrations of urea, arginine)

    • Inclusion of stabilizers (glycerol 5-10%, reducing agents)

    • Optimization of pH and ionic strength

  • Protein engineering approaches:

    • Surface entropy reduction

    • Removal of hydrophobic patches

    • Introduction of solubility-enhancing mutations

The multivariant experimental design approach is particularly effective for identifying optimal conditions for soluble expression .

What quality control measures ensure functional integrity of purified Recombinant Cicadin?

Comprehensive quality control ensures research reproducibility and reliability:

  • Purity assessment:

    • SDS-PAGE (>95% homogeneity)

    • Size exclusion chromatography

    • Mass spectrometry for accurate mass determination

  • Structural verification:

    • Circular dichroism for secondary structure confirmation

    • Dynamic light scattering for aggregation analysis

    • Thermal shift assays for stability assessment

  • Functional analysis:

    • Activity assays compared to native protein standards

    • Binding studies with known interaction partners

    • Structure-based analyses comparing to known homologs

  • Stability monitoring:

    • Accelerated stability studies at elevated temperatures

    • Freeze-thaw cycle tolerance

    • Long-term storage condition optimization

These quality control measures should be standardized across laboratories to ensure consistent research outcomes, similar to approaches used for other complex recombinant proteins .

How might Recombinant Cicadin be utilized in comparative evolutionary studies?

The application of Recombinant Cicadin in evolutionary research offers several promising directions:

  • Expression of Cicadin variants from different cicada species to compare functional properties

  • Reconstruction of ancestral Cicadin sequences through computational methods

  • Analysis of structure-function relationships across evolutionary divergent cicada species

  • Identification of conserved functional domains versus species-specific variations

Such comparative studies would benefit from the non-invasive sampling techniques using cicada exuviae, allowing for broad species sampling without harming endangered populations .

What techniques can enhance functional characterization of Recombinant Cicadin?

Advanced functional characterization requires sophisticated methodological approaches:

  • Real-time activity monitoring using fluorescent reporters

  • Single-molecule analysis to observe individual protein behavior

  • Cryo-EM studies to capture different conformational states

  • Hydrogen-deuterium exchange mass spectrometry to map dynamic regions

  • In silico molecular dynamics simulations to predict functional mechanisms

Similar approaches have provided insights into complex enzymes like RecBCD, revealing how conformational changes control enzyme activity .

How can heterologous expression systems be optimized for authentic post-translational modifications?

When authentic post-translational modifications are critical for Cicadin function:

  • Identify native modifications in cicada-derived Cicadin using mass spectrometry

  • Select expression systems capable of performing required modifications:

    • Glycosylation patterns (yeast, insect, or mammalian cells)

    • Phosphorylation (mammalian cells with appropriate kinases)

    • Disulfide bond formation (periplasmic expression or eukaryotic systems)

  • Engineer host cells to express cicada-specific modification enzymes

  • Perform in vitro enzymatic modifications post-purification

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.